Dexmedetomidine in Topical Versus Peribulbar Anesthesia for Cataract Surgery

• Status: Not yet recruiting
• Trial end date: 2023-07-15
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to compare efficacy of dexmedetomidine as an additive to topical versus peribulbar anesthesia for cataract surgery

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kafrelsheikh University
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• American Society of Anesthesiologists (ASA) physical status classification I or II who scheduled for eye surgery

Exclusion Criteria:

• Patients who are younger than 18 years

• The usual contraindications for regional anesthesia such as patients refusing LA

• Clotting abnormalities

• Impaired mental status

• Allergy to any of the study medications

• patients had the severe cardiac disease

• chronic obstructive lung disease and a history of sleep apnea

• contraindications to the use of dexmedetomidine

• history or significant cardiovascular disease risk factors

• significant coronary artery disease or any known genetic predisposition

• history of any kind of drug allergy

• drug abuse

• psychological or other emotional problems

• special diet or lifestyle

• clinically significant abnormal findings in physical examination

• electrocardiographic (ECG) or laboratory screening

• known systemic disease requiring the use of anticoagulants.